KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Treasury Shares (2017 - 2025)

Medtronic's Treasury Shares history spans 11 years, with the latest figure at $38.0 million for Q2 2025.

  • On a quarterly basis, Treasury Shares rose 52.0% to $38.0 million in Q2 2025 year-over-year; TTM through Apr 2025 was $38.0 million, a 52.0% increase, with the full-year FY2025 number at $38.0 million, up 52.0% from a year prior.
  • Treasury Shares hit $38.0 million in Q2 2025 for Medtronic, up from $25.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for MDT hit a ceiling of $38.0 million in Q2 2025 and a floor of $4.0 million in Q2 2021.
  • Historically, Treasury Shares has averaged $22.2 million across 4 years, with a median of $23.5 million in 2022.
  • Biggest five-year swings in Treasury Shares: crashed 66.67% in 2021 and later surged 450.0% in 2022.
  • Tracing MDT's Treasury Shares over 4 years: stood at $4.0 million in 2021, then surged by 450.0% to $22.0 million in 2022, then grew by 13.64% to $25.0 million in 2024, then skyrocketed by 52.0% to $38.0 million in 2025.
  • Business Quant data shows Treasury Shares for MDT at $38.0 million in Q2 2025, $25.0 million in Q2 2024, and $22.0 million in Q2 2022.